ASTRAZEN - Astrazeneca Pharma India

Astrazeneca Pharma India

ASTRAZEN · Pharma > Pharmaceuticals & Drugs · Chairman: Narayan K Seshadri · MD: Gagandeep Singh Bedi · Listing date: July 29, 1998 · Employees: 1283 · Bangalore · http://www.astrazeneca.in

Stock Price vs Company Growth

0.4%

0.8%

9.2%

10.5%

5.8%

18.0%

17.7%

10y

21.5%

all

15.2%

🤔 How to analyze this graph?

Last Traded Price

₹ 8,316 0.4%

8,027

9,850

Company Overview

Sales

2,006 Cr

Growth: 28.5%

Profit after Tax

199 Cr

Growth: 8.6%

Mid Cap

20,791 Cr

P/E: 103.8x

Industry P/E: 30.0x

Fundamentals

Sales (Cr)	₹ 2,006
Growth	28.5%
EBITDA	15.9%
P/S	10.3x
Dividend	0.3%
P/E	103.8x
Book Value	₹ 352
PEG Ratio	3.6x
ROE	24.5%
P/B	23.4x

Shareholding Pattern

Institutions

Promoters

Astrazeneca Pharmaceuticals Ab

75.0 %

Others

Tejas Bhalchandra Trivedi

2.67 %

Shivani T. Trivedi

1.98 %

Minaxi Bhalchandra Trivedi

1.84 %

Iepf

0.46 %

Increase Decrease No change

Company Profile Detailed

The Company is engaged in the business of manufacture, distribution and marketing of life-changing medicines in crucial areas of healthcare including oncology, cardiovascular, diabetes, renal, metabolic and respiratory.Core Therapy AreasCardiovascularOncologyRespiratoryMilestones and achievements1979: Astra IDL formation.1982: Astra factory foundation.1992: Launch of Cerviprime, Plendil, Ramace, Rhinocort and Imdur.

Belongs to (24 Indices) view more

Investors (43)

astra.ph...

all.body...

mansfiel...

Followers (3)

nitin2

keerthi

deepak